Beth's comprehensive review highlights the critical need for harmonisation in SCD measurement and the importance of including diverse populations in research. The emphasis on combining informant reports with self-assessment for a richer understanding of SCD's impact is particularly insightful. It underscores a multidimensional approach to Alzheimer's research, encouraging us to consider cognitive decline through both objective and subjective lenses. This could significantly advance our ability to identify early Alzheimer's markers and develop tailored interventions - this is something that MUST be considered alongside the Blood Biomarkers.
Dr Beth Eyre's latest blog brings us highlights from last months ISTAART Alzheimer's Association Subjective Cognitive Decline PIA Year in Review. Sharing insights into Alzheimer's research, highlighting key findings, the importance of diverse research, and the need for standardized SCD measurement, it's a must-read for professionals in the field. A testament to the power of collaboration and innovation in tackling Alzheimer's. #AlzheimersResearch #SCD
https://lnkd.in/d87HMwtB